Phathom Pharmaceuticals, Inc. (PHAT)
11.98
+0.10
(+0.84%)
USD |
NASDAQ |
Feb 19, 16:00
11.96
-0.02
(-0.13%)
After-Hours: 20:00
Phathom Pharmaceuticals EPS Diluted (Quarterly) : -0.4084 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MannKind Corp. | 0.0256 |
| Vanda Pharmaceuticals, Inc. | -2.389 |
| Ocugen, Inc. | -0.066 |
| Immuneering Corp. | -0.3772 |
| Invivyd, Inc. | -0.0615 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.97M |
| Revenue (Quarterly) | 49.50M |
| Total Expenses (Quarterly) | 79.48M |
| Enterprise Value | 1.383B |
| Gross Profit Margin (Quarterly) | 87.50% |
| Profit Margin (Quarterly) | -60.55% |
| Earnings Yield | -31.83% |
| Normalized Earnings Yield | -31.83 |